Galderma Shareholders Approve All Annual General Meeting Proposals

Contributed by: Business Wire

Logo

Tags

Biotechnology

General Health

Other Health

Health

Pharmaceutical

Galderma Group AG

More Like This

Galderma Publishes Invitation and Agenda for Its 2026 Annual General Meeting

Galderma Publishes its 2024 Annual Report and the Invitation to Its First Annual General Meeting

Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth

Galderma Welcomes Increased Equity Investment From L’Oréal

Galderma Announces Full Exercise of Over-Allotment Option

Galderma Announces Intention to Float on the SIX Swiss Exchange

Galderma Prices IPO at CHF 53 Per Share and Will Start Trading on the SIX Swiss Exchange Tomorrow

Galderma Buys Back Shares Worth CHF 233 Million in the Context of Accelerated Bookbuild Offering